2024-10-27 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Stock Performance:**

Intuitive Surgical Inc. (ISRG) has significantly outperformed the S&P 500 (VOO) in the long term. As of today, ISRG's cumulative return is 370.05%, compared to 135.48% for the S&P 500. This represents a massive difference of 234.57%, which translates to an 80.85% relative outperformance compared to its historical range. This indicates that ISRG has been a strong performer, consistently exceeding the broader market returns.

**2. Recent Price Movements:**

* **Closing Price:** 511.63
* **5-Day Moving Average:** 516.34
* **20-Day Moving Average:** 490.63
* **60-Day Moving Average:** 482.05

ISRG's recent price action shows a slight dip compared to its 5-day moving average but remains above its 20-day and 60-day moving averages, suggesting potential upside momentum.

**3. Technical Indicators:**

* **RSI:** 63.37 –  Indicates a moderately overbought condition, suggesting potential for a pullback.
* **PPO:** 0.67 –  Suggests a positive momentum, consistent with the price action above moving averages.
* **Delta_Previous_Relative_Divergence:** 5.61 (+) –  Shows a positive divergence in the recent 20-day period, suggesting potential for further upside movement.
* **Expected Return:** 12.43% –  Indicates a potential for 12.43% excess return compared to the S&P 500 in the long term (2 years or more).

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2024-10-18 | 1.18 | 1.74 B$ |

* **Most Recent Earnings (2024-10-18):** ISRG beat analysts' EPS estimates, exceeding the predicted 1.37 by 0.22. Revenue also surpassed expectations, exceeding the projected 1.99 B$ by 0.05 B$.

**5. News & Recent Events:**

* **Recent Earnings News:** The recent earnings call on October 18th was generally positive, highlighting the company's strong performance and continued market share growth. Analysts praised the company's focus on innovation and expansion into new markets.

* **Market Outlook:**  Analysts are generally positive on ISRG's future prospects. Finbold reports a consensus "Buy" rating with an average price target of $547.17. They highlight ISRG's dominance in the robotic surgery market, its expanding portfolio of procedures, and the increasing adoption of minimally invasive surgeries as key drivers of growth.

**6. Comprehensive Analysis:**

Intuitive Surgical Inc. has proven itself to be a strong long-term performer. The company has consistently outperformed the S&P 500, with its recent price action and technical indicators suggesting potential for further upside. The recent positive earnings call and analysts' positive outlook support this narrative. While the RSI suggests a moderately overbought condition, the potential for growth in the robotics surgery market and ISRG's position as a leader in this space remains a strong positive factor. 

**7. Conclusion:**

ISRG remains a compelling investment for long-term investors. Its history of outperformance, recent strong earnings, and positive market outlook all suggest potential for continued growth. The company's dominance in the robotic surgery market and the increasing adoption of minimally invasive procedures offer significant long-term growth opportunities. While the recent technical indicators suggest potential for a pullback, ISRG remains a strong buy for investors seeking exposure to the healthcare sector and the emerging technology of robotic surgery. 
